| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Scilex Holding Co | Director | Common Stock | 25K | $23.7K | $0.95 | Oct 17, 2024 | Direct |
| CASI Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 388K | May 25, 2022 | Direct | ||
| Sorrento Therapeutics, Inc. | Director | Stock option (right to buy) | 250K | Aug 30, 2021 | Direct | ||
| Scilex Holding Co | Director | Nonstatutory Stock Option (right to buy) | 245K | Jun 20, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SCLX | Scilex Holding Co | Oct 17, 2024 | 1 | $19K | 4 | Oct 18, 2024 | Director |
| SCLX | Scilex Holding Co | Jun 20, 2024 | 2 | $7.05K | 4 | Jun 20, 2024 | Director |
| SCLX | Scilex Holding Co | Oct 4, 2023 | 1 | $0 | 4 | Oct 5, 2023 | Director |
| SCLX | Scilex Holding Co | Sep 22, 2023 | 0 | $0 | 3 | Sep 25, 2023 | Director |
| CASI | CASI Pharmaceuticals, Inc. | May 25, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
| SRNEQ | Sorrento Therapeutics, Inc. | Aug 30, 2021 | 1 | $0 | 4 | Aug 30, 2021 | Director |
| CASI | CASI Pharmaceuticals, Inc. | Jun 15, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |